BACKGROUND AND OBJECTIVES: Growth and final height are of major concern in children with ESRD. This study sought to describe the distribution of adult height of patients who started renal replacement therapy (RRT) during childhood and to identify determinants of final height in a large cohort of RRT children. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A total of 1612 patients from 20 European countries who started RRT before 19 years of age and reached final height between 1990 and 2011 were included. Linear regression analyses were performed to calculate adjusted mean final height SD score (SDS) and to investigate its potential determinants. RESULTS: The median final height SDS was -1.65 (median of 168 cm in boys and 155 cm in girls). Fifty-five percent of patients attained an adult height within the normal range. Adjusted for age at start of RRT and primary renal diseases, final height increased significantly over time from -2.06 SDS in children who reached adulthood in 1990-1995 to -1.33 SDS among those reaching adulthood in 2006-2011. Older age at start of RRT, more recent period of start of RRT, cumulative percentage time on a functioning graft, and greater height SDS at initiation of RRT were independently associated with a higher final height SDS. Patients with congenital anomalies of the kidney and urinary tract and metabolic disorders had a lower final height than those with other primary renal diseases. CONCLUSIONS: Although final height remains suboptimal in children with ESRD, it has consistently improved over time.
BACKGROUND AND OBJECTIVES: Growth and final height are of major concern in children with ESRD. This study sought to describe the distribution of adult height of patients who started renal replacement therapy (RRT) during childhood and to identify determinants of final height in a large cohort of RRT children. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A total of 1612 patients from 20 European countries who started RRT before 19 years of age and reached final height between 1990 and 2011 were included. Linear regression analyses were performed to calculate adjusted mean final height SD score (SDS) and to investigate its potential determinants. RESULTS: The median final height SDS was -1.65 (median of 168 cm in boys and 155 cm in girls). Fifty-five percent of patients attained an adult height within the normal range. Adjusted for age at start of RRT and primary renal diseases, final height increased significantly over time from -2.06 SDS in children who reached adulthood in 1990-1995 to -1.33 SDS among those reaching adulthood in 2006-2011. Older age at start of RRT, more recent period of start of RRT, cumulative percentage time on a functioning graft, and greater height SDS at initiation of RRT were independently associated with a higher final height SDS. Patients with congenital anomalies of the kidney and urinary tract and metabolic disorders had a lower final height than those with other primary renal diseases. CONCLUSIONS: Although final height remains suboptimal in children with ESRD, it has consistently improved over time.
Authors: A M Fredriks; S van Buuren; R J Burgmeijer; J F Meulmeester; R J Beuker; E Brugman; M J Roede; S P Verloove-Vanhorick; J M Wit Journal: Pediatr Res Date: 2000-03 Impact factor: 3.756
Authors: Rulan S Parekh; Joseph T Flynn; William E Smoyer; Joan L Milne; David B Kershaw; Timothy E Bunchman; Aileen B Sedman Journal: J Am Soc Nephrol Date: 2001-11 Impact factor: 10.121
Authors: Michel Broyer; Christine Le Bihan; Marina Charbit; Genevieve Guest; Marie-Josephe Tete; Marie France Gagnadoux; Patrick Niaudet Journal: Transplantation Date: 2004-04-15 Impact factor: 4.939
Authors: Susan L Furth; Wenke Hwang; Ching Yang; Alicia M Neu; Barbara A Fivush; Neil R Powe Journal: Pediatr Nephrol Date: 2002-06 Impact factor: 3.714
Authors: Eujin Park; Hye Jin Lee; Hyun Jin Choi; Yo Han Ahn; Kyoung Hee Han; Seong Heon Kim; Heeyeon Cho; Jae Il Shin; Joo Hoon Lee; Young Seo Park; Il-Soo Ha; Min Hyun Cho; Hee Gyung Kang Journal: Pediatr Nephrol Date: 2021-03-30 Impact factor: 3.714
Authors: Elaine Ku; Richard N Fine; Chi-Yuan Hsu; Charles McCulloch; David V Glidden; Barbara Grimes; Kirsten L Johansen Journal: Clin J Am Soc Nephrol Date: 2016-03-01 Impact factor: 8.237